Towards targeted combinatorial therapy design for the treatment of castration-resistant prostate cancer

BACKGROUND: Prostate cancer is one of the most prevalent cancers in males in the United States and amongst the leading causes of cancer related deaths. A particularly virulent form of this disease is castration-resistant prostate cancer (CRPC), where patients no longer respond to medical or surgical...

Descripción completa

Detalles Bibliográficos
Autores principales: Arshad, Osama Ali, Datta, Aniruddha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374594/
https://www.ncbi.nlm.nih.gov/pubmed/28361666
http://dx.doi.org/10.1186/s12859-017-1522-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374594/
https://www.ncbi.nlm.nih.gov/pubmed/28361666
http://dx.doi.org/10.1186/s12859-017-1522-2

Ejemplares similares